Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis

Por Wang, Xiaoyan, Wang, Jian-Ping, Maughan, Maureen F, Lachman, Lawrence B
Publicado em 2005

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

Por Eralp, Yesim, Wang, Xiaoyan, Wang, Jian-Ping, Maughan, Maureen F, Polo, John M, Lachman, Lawrence B
Publicado em 2004

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity

Por Avogadri, Francesca, Merghoub, Taha, Maughan, Maureen F., Hirschhorn-Cymerman, Daniel, Morris, John, Ritter, Erika, Olmsted, Robert, Houghton, Alan N., Wolchok, Jedd D.
Publicado em 2010

Combination of Alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates

Por Avogadri, Francesca, Zappasodi, Roberta, Yang, Arvin, Budhu, Sadna, Malandro, Nicole, Hirshhorn-Cymerman, Daniel, Tiwari, Shakuntala, Maughan, Maureen F., Olmsted, Robert, Wolchok, Jedd D, Merghoub, Taha
Publicado no Cancer Immunol Res (2014)